Company Name or Ticker Symbol
Search for other Categories

Ait Therapeutics, Inc.  (AITB)
Other Ticker:  
    Sector  Healthcare    Industry Medical Equipment & Supplies

Ait Therapeutics's ROA per quarter

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

Select the Comparisons : Select the Ratio:                        

Return On Assets (Mar 31 2017)
I. Quarter

Y / Y Total Assets Change - - - - -
Y / Y Net Income Change - - - - -
Return On Assets (TTM) 339.71 % - - - -
Total Ranking # # # # #
Seq. Total Assets Change - - - - -
Seq. Net Income Change - - - - -

Roa Comment
Ait Therapeutics, Inc. yielded Return on Asset in I. Quarter above company average, at 339.71 %.

ROA improved compare to previous quarter, due to net income growth.

Within Healthcare sector Ait Therapeutics, Inc. achieved highest return on assets. While total ranking remained unchanged compare to previous quarter at no. .

What is ROA?
Return On Assets Company Ranking
Within: No.
Industry #
Sector #
Overall # 0

Return On Assets Statistics
High Average Low
0 %
0 %
0 %

You need to upgrade your Flash Player
Financial Statements
Ait Therapeutics's Equity $ 1 Millions AITB's Balance sheet
Ait Therapeutics's Income $ 6 Millions Quarterly AITB's Income Statement
AITB's Income by Division See AITB's Income by Division

More Return On Equity Ratios
Medical Equipment & Supplies Industry Return On Asstes Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
AITB's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Asstes
Lowest Ranking Return On Asstes
Roa for AITB's Competitors
Roa for Ait Therapeutics's Suppliers
Return On Asstes for AITB's Customers

You may also want to know
AITB's Roi AITB's Inventory Turnover Ratio AITB's Growth Rates AITB's Dividend Comparisons
AITB's Annual Roi AITB's Profitability Ratios AITB's Asset Turnover Ratio AITB's Dividend Growth
AITB's Roe AITB's Valuation Ratios AITB's Financial Strength Ratios AITB's Dividend Payout Ratio

Companies with similar Return On Assets at Mar 31 2017, within Healthcare Sector ROA
Regenerx Biopharmaceuticals Inc  349.48 %
Pharmathene, Inc  219.02 %
Prophase Labs, Inc.  182.12 %
Ophthalix, Inc.  169.96 %
Steadymed Ltd.  145.38 %
International Stem Cell Corp  137.42 %
Capstone Therapeutics Corp.  133.50 %
Greenestone Healthcare Corp  127.56 %
Mannkind Corp  125.49 %
Nascent Biotech Inc.  113.05 %
Tenax Therapeutics, Inc.  100.61 %
Neurometrix, Inc.  77.36 %
Elite Pharmaceuticals Inc  70.86 %

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com